CH-0793076 TFA

CH-0793076 TFA is a hexacyclic camptothecin analog and the major active metabolite of TP300. It functions as a topoisomerase I inhibitor with an IC50 of 2.3 μM and demonstrates efficacy against cancer cells expressing the BCRP drug-resistance transporter, making it a compound of interest for oncology research in both cellular and animal models.